Demystifying Evidence for Antiplatelet De-escalation in ASCVD

Explore the complex topic of antiplatelet de-escalation strategies for atherosclerotic cardiovascular disease (ASCVD) in this 49-minute Cardiovascular Grand Rounds presentation by Matt Lillyblad, PharmD, BCCCP, BCCP from the Minneapolis Heart Institute Foundation®. Learn about the current evidence base, clinical considerations, and practical approaches to antiplatelet therapy modification in patients with established cardiovascular disease. Understand when and how to safely transition patients between different antiplatelet regimens based on their risk profiles, comorbidities, and clinical presentation.